A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.

about

A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.

Item

http://www.wikidata.org/entity/Q40329955

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.

@en

type

Item

label

A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.

@en

prefLabel

A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.

@en

P1476

A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.

@en

P2093

Christopher P Cannon

http://www.w3.org/2001/XMLSchema#string

Dalton S McLean

http://www.w3.org/2001/XMLSchema#string

P2860

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Clopidogrel resistance: a new chapter in a fast-moving story

Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study

Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes

Does clopidogrel increase blood loss following coronary artery bypass surgery?

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

P304

255-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14796678.2.3.255

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19804082

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel